148 related articles for article (PubMed ID: 28883376)
1. In vitro Evaluation of Acyclovir/Chitosan Floating Systems.
Ruiz-Caro R; Veiga MD
Materials (Basel); 2010 Dec; 3(12):5195-5211. PubMed ID: 28883376
[TBL] [Abstract][Full Text] [Related]
2. Characterization and dissolution study of chitosan freeze-dried systems for drug controlled release.
Ruiz-Caro R; Veiga-Ochoa MD
Molecules; 2009 Oct; 14(11):4370-86. PubMed ID: 19924071
[TBL] [Abstract][Full Text] [Related]
3. Mucoadhesive tablets for controlled release of acyclovir.
Ruiz-Caro R; Gago-Guillan M; Otero-Espinar FJ; Veiga MD
Chem Pharm Bull (Tokyo); 2012; 60(10):1249-57. PubMed ID: 22863800
[TBL] [Abstract][Full Text] [Related]
4. Development of mucoadhesive floating hollow beads of acyclovir with gastroretentive properties.
Svirskis D; Seyfoddin A; Chalabi S; In Kim JH; Langford C; Painter S; Al-Kassas R
Pharm Dev Technol; 2014 Aug; 19(5):571-6. PubMed ID: 23859639
[TBL] [Abstract][Full Text] [Related]
5. Development and evaluation of a monolithic floating drug delivery system for acyclovir.
Tavakoli N; Varshosaz J; Dorkoosh F; Motaghi S; Tamaddon L
Chem Pharm Bull (Tokyo); 2012; 60(2):172-7. PubMed ID: 22293475
[TBL] [Abstract][Full Text] [Related]
6. Development and evaluation of alginate-chitosan gastric floating beads loading with oxymatrine solid dispersion.
Liu Y; Chen L; Zhou C; Yang J; Hou Y; Wang W
Drug Dev Ind Pharm; 2016; 42(3):456-63. PubMed ID: 26422447
[TBL] [Abstract][Full Text] [Related]
7. Physical characterizations and sustained release profiling of gastroretentive drug delivery systems with improved floating and swelling capabilities.
Chen YC; Ho HO; Lee TY; Sheu MT
Int J Pharm; 2013 Jan; 441(1-2):162-9. PubMed ID: 23237874
[TBL] [Abstract][Full Text] [Related]
8. The role of lipid-based drug delivery systems for enhancing solubility of highly selective antiviral agent acyclovir.
Kazi M; Al-Amri KA; Alanazi FK
Pharm Dev Technol; 2017 May; 22(3):312-321. PubMed ID: 26458371
[TBL] [Abstract][Full Text] [Related]
9. Chitosan/Xanthan Gum Based Hydrogels as Potential Carrier for an Antiviral Drug: Fabrication, Characterization, and Safety Evaluation.
Malik NS; Ahmad M; Minhas MU; Tulain R; Barkat K; Khalid I; Khalid Q
Front Chem; 2020; 8():50. PubMed ID: 32117876
[TBL] [Abstract][Full Text] [Related]
10. Nano and microparticulate chitosan-based systems for antiviral topical delivery.
Calderón L; Harris R; Cordoba-Diaz M; Elorza M; Elorza B; Lenoir J; Adriaens E; Remon JP; Heras A; Cordoba-Diaz D
Eur J Pharm Sci; 2013 Jan; 48(1-2):216-22. PubMed ID: 23159663
[TBL] [Abstract][Full Text] [Related]
11. Effects of synthesis conditions and release medium pH on release properties of acyclovir - mercaptopropyl modified silica composite.
Dolinina ES; Akimsheva EY; Parfenyuk EV
Drug Dev Ind Pharm; 2021 Oct; 47(10):1624-1632. PubMed ID: 35107404
[TBL] [Abstract][Full Text] [Related]
12. Development of Acyclovir-Loaded Albumin Nanoparticles and Improvement of Acyclovir Permeation Across Human Corneal Epithelial T Cells.
Suwannoi P; Chomnawang M; Sarisuta N; Reichl S; Müller-Goymann CC
J Ocul Pharmacol Ther; 2017 Dec; 33(10):743-752. PubMed ID: 29111864
[TBL] [Abstract][Full Text] [Related]
13. Acyclovir delivery matrices based on poly(ethylene glycol)/chitosan semi-interpenetrating networks.
Diez-Sales O; Dolz M; Hernandez MJ; Casanovas A; Herraez M
J Pharm Sci; 2007 Jun; 96(6):1653-7. PubMed ID: 17286301
[TBL] [Abstract][Full Text] [Related]
14. Interpolymer complexes of poly(acrylic acid) and chitosan: influence of the ionic hydrogel-forming medium.
de la Torre PM; Torrado S; Torrado S
Biomaterials; 2003 Apr; 24(8):1459-68. PubMed ID: 12527287
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of laminated thiolated chitosan-based freeze-dried wafers for potential buccal delivery of macromolecules.
Boateng JS; Ayensu I
Drug Dev Ind Pharm; 2014 May; 40(5):611-8. PubMed ID: 24506457
[TBL] [Abstract][Full Text] [Related]
16. Formulation and evaluation of different floating tablets containing metronidazole to target stomach.
Loh ZC; Elkordy AA
Curr Drug Deliv; 2015; 12(4):425-43. PubMed ID: 25924732
[TBL] [Abstract][Full Text] [Related]
17. Formulation of acyclovir-loaded solid lipid nanoparticles: 2. Brain targeting and pharmacokinetic study.
El-Gizawy SA; El-Maghraby GM; Hedaya AA
Pharm Dev Technol; 2019 Dec; 24(10):1299-1307. PubMed ID: 31507245
[TBL] [Abstract][Full Text] [Related]
18. Transcorneal permeation of L- and D-aspartate ester prodrugs of acyclovir: delineation of passive diffusion versus transporter involvement.
Majumdar S; Hingorani T; Srirangam R; Gadepalli RS; Rimoldi JM; Repka MA
Pharm Res; 2009 May; 26(5):1261-9. PubMed ID: 18839288
[TBL] [Abstract][Full Text] [Related]
19. Comparison of liposome-encapsulated acyclovir with acyclovir ointment: ocular pharmacokinetics in rabbits.
Chetoni P; Rossi S; Burgalassi S; Monti D; Mariotti S; Saettone MF
J Ocul Pharmacol Ther; 2004 Apr; 20(2):169-77. PubMed ID: 15117573
[TBL] [Abstract][Full Text] [Related]
20. Formulation development, optimization, and evaluation of sustained release tablet of valacyclovir hydrochloride by combined approach of floating and swelling for better gastric retention.
Upadhyay P; Nayak K; Patel K; Patel J; Shah S; Deshpande J
Drug Deliv Transl Res; 2014 Dec; 4(5-6):452-64. PubMed ID: 25787207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
